ASX - By Stock
|
TEM |
Re:
Ann: $8.44M Placement to fast track exploration at Yalgoo
|
|
avagadro
|
38 |
15K |
1 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
38
|
15K
|
1
|
|
ASX - By Stock
|
SPA |
Re:
Ann: Launch of Jumpy Sim MVNO in USA
|
|
avagadro
|
8 |
2.5K |
3 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
8
|
2.5K
|
3
|
|
ASX - By Stock
|
TEM |
Re:
Ann: $8.44M Placement to fast track exploration at Yalgoo
|
|
avagadro
|
38 |
15K |
0 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
38
|
15K
|
0
|
|
ASX - By Stock
|
SPA |
Re:
Ann: Launch of Jumpy Sim MVNO in USA
|
|
avagadro
|
8 |
2.5K |
0 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
8
|
2.5K
|
0
|
|
ASX - By Stock
|
SPA |
Re:
Ann: Launch of Jumpy Sim MVNO in USA
|
|
avagadro
|
8 |
2.5K |
0 |
26/04/22 |
26/04/22 |
ASX - By Stock
|
8
|
2.5K
|
0
|
|
Charts
|
4DS |
Re:
4DS Chart for Long Term Holders
|
|
avagadro
|
1.5K |
664K |
3 |
21/04/22 |
21/04/22 |
Charts
|
1.5K
|
664K
|
3
|
|
ASX - By Stock
|
VML |
Re:
Ann: Trading Halt
|
|
avagadro
|
102 |
65K |
15 |
21/04/22 |
21/04/22 |
ASX - By Stock
|
102
|
65K
|
15
|
|
ASX - By Stock
|
TEM |
Re:
Ann: $8.44M Placement to fast track exploration at Yalgoo
|
|
avagadro
|
38 |
15K |
3 |
19/04/22 |
19/04/22 |
ASX - By Stock
|
38
|
15K
|
3
|
|
ASX - By Stock
|
GTH |
Re:
Ann: Half Year Results and Market Update
|
|
avagadro
|
2 |
1.7K |
0 |
14/04/22 |
14/04/22 |
ASX - By Stock
|
2
|
1.7K
|
0
|
|
ASX - By Stock
|
4DS |
Re:
Ann: 4DS Technical Update
|
|
avagadro
|
487 |
185K |
5 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
487
|
185K
|
5
|
|
ASX - By Stock
|
GED |
Re:
multibagger potential with soaring V2O5 price
|
|
avagadro
|
142 |
30K |
1 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
142
|
30K
|
1
|
|
ASX - By Stock
|
GED |
Re:
multibagger potential with soaring V2O5 price
|
|
avagadro
|
142 |
30K |
4 |
08/04/22 |
08/04/22 |
ASX - By Stock
|
142
|
30K
|
4
|
|
ASX - By Stock
|
GED |
Re:
Ann: GED Raises $7.2M to Accelerate Development Programs
|
|
avagadro
|
147 |
73K |
6 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
147
|
73K
|
6
|
|
ASX - By Stock
|
GED |
Re:
Ann: GED Raises $7.2M to Accelerate Development Programs
|
|
avagadro
|
147 |
73K |
7 |
07/04/22 |
07/04/22 |
ASX - By Stock
|
147
|
73K
|
7
|
|
ASX - By Stock
|
GED |
Re:
Ann: GED Presentation Battery Minerals Conference 6-7 April 22
|
|
avagadro
|
9 |
4.0K |
3 |
06/04/22 |
06/04/22 |
ASX - By Stock
|
9
|
4.0K
|
3
|
|
ASX - By Stock
|
GED |
Re:
Ann: Trading Halt
|
|
avagadro
|
112 |
35K |
5 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
112
|
35K
|
5
|
|
ASX - By Stock
|
GED |
Re:
Ann: Trading Halt
|
|
avagadro
|
112 |
35K |
10 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
112
|
35K
|
10
|
|
ASX - By Stock
|
GED |
Re:
Ann: Exceptional Copper-Vanadium Intersection at Nosib
|
|
avagadro
|
50 |
20K |
6 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
50
|
20K
|
6
|
|
ASX - By Stock
|
GED |
Re:
Ann: Outstanding Vanadium Extraction of up to 95% from Abenab
|
|
avagadro
|
39 |
13K |
5 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
39
|
13K
|
5
|
|
ASX - By Stock
|
LTR |
Re:
ASX Today
|
|
avagadro
|
41K |
18M |
9 |
04/04/22 |
04/04/22 |
ASX - By Stock
|
41K
|
18M
|
9
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
0 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
808
|
260K
|
0
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
9 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
808
|
260K
|
9
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
4 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
808
|
260K
|
4
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
3 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
808
|
260K
|
3
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
1 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
808
|
260K
|
1
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
1 |
31/03/22 |
31/03/22 |
ASX - By Stock
|
808
|
260K
|
1
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
10 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
808
|
260K
|
10
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
9 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
808
|
260K
|
9
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
3 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
808
|
260K
|
3
|
|
ASX - By Stock
|
TEM |
Re:
Ann: Meleya Update - Significant Discovery At Orion Target
|
|
avagadro
|
808 |
260K |
6 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
808
|
260K
|
6
|
|
ASX - General
|
|
Re:
XJO, Gold, MOY and others
|
|
avagadro
|
11K |
3.5M |
1 |
29/03/22 |
29/03/22 |
ASX - General
|
11K
|
3.5M
|
1
|
|
ASX - General
|
|
Re:
XJO, Gold, MOY and others
|
|
avagadro
|
11K |
3.5M |
1 |
28/03/22 |
28/03/22 |
ASX - General
|
11K
|
3.5M
|
1
|
|
ASX - General
|
|
Re:
XJO, Gold, MOY and others
|
|
avagadro
|
11K |
3.5M |
2 |
28/03/22 |
28/03/22 |
ASX - General
|
11K
|
3.5M
|
2
|
|
ASX - By Stock
|
SPA |
Re:
More Noise
|
|
avagadro
|
186 |
63K |
0 |
28/03/22 |
28/03/22 |
ASX - By Stock
|
186
|
63K
|
0
|
|
ASX - By Stock
|
FMG |
Re:
Iron ore price
|
|
avagadro
|
52K |
28M |
0 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
52K
|
28M
|
0
|
|
ASX - By Stock
|
SPA |
Re:
More Noise
|
|
avagadro
|
186 |
63K |
0 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
186
|
63K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
avagadro
|
115 |
43K |
0 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
115
|
43K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
avagadro
|
115 |
43K |
0 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
115
|
43K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
avagadro
|
115 |
43K |
0 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
115
|
43K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
avagadro
|
115 |
43K |
0 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
115
|
43K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
avagadro
|
115 |
43K |
0 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
115
|
43K
|
0
|
|
ASX - By Stock
|
SPA |
Re:
More Noise
|
|
avagadro
|
186 |
63K |
1 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
186
|
63K
|
1
|
|
ASX - By Stock
|
4DS |
Re:
Ann: Appointment of New CEO & Managing Director
|
|
avagadro
|
195 |
69K |
8 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
195
|
69K
|
8
|
|
ASX - By Stock
|
ADO |
Re:
Any positives?
|
|
avagadro
|
316 |
100K |
2 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
316
|
100K
|
2
|
|
ASX - By Stock
|
ADO |
Re:
Any positives?
|
|
avagadro
|
316 |
100K |
0 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
316
|
100K
|
0
|
|
ASX - By Stock
|
BSE |
Re:
Ann: Quarterly Activities Report - December 2021
|
|
avagadro
|
217 |
56K |
2 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
217
|
56K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: MD Anderson Preclinical AML Study on Zantrene Published
|
|
avagadro
|
54 |
18K |
0 |
27/02/22 |
27/02/22 |
ASX - By Stock
|
54
|
18K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: MD Anderson Preclinical AML Study on Zantrene Published
|
|
avagadro
|
54 |
18K |
2 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
54
|
18K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: MD Anderson Preclinical AML Study on Zantrene Published
|
|
avagadro
|
54 |
18K |
0 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
54
|
18K
|
0
|
|
ASX - By Stock
|
BSE |
Re:
Ann: Quarterly Activities Report - December 2021
|
|
avagadro
|
217 |
56K |
0 |
25/02/22 |
25/02/22 |
ASX - By Stock
|
217
|
56K
|
0
|
|